We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+0.55%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$48B
AUM Growth
-$1.59B
Cap. Flow
-$1.46B
Cap. Flow %
-3.05%
Top 10 Hldgs %
24.06%
Holding
1,904
New
84
Increased
534
Reduced
502
Closed
55

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$60.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$50.8M
3
MA icon
Mastercard
MA
+$43.1M
4
ADI icon
Analog Devices
ADI
+$40.3M
5
AVGO icon
Broadcom
AVGO
+$40.1M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$92.3M
2
NVDA icon
NVIDIA
NVDA
+$92.1M
3
LLY icon
Eli Lilly
LLY
+$80.8M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$74.2M
5
MSFT icon
Microsoft
MSFT
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 24.14%
2 Financials 15.08%
3 Healthcare 14.69%
4 Consumer Discretionary 11.11%
5 Communication Services 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNBR
901
DELISTED
Sleep Number
SNBR
$2.91M 0.01%
31,084
AUPH icon
902
Aurinia Pharmaceuticals
AUPH
$1.92B
$2.9M 0.01%
131,203
-20,396
-13% -$324K
MTB icon
903
M&T Bank
MTB
$36.6B
$2.9M 0.01%
19,429
+7,825
+67% +$1.08M
QLYS icon
904
Qualys
QLYS
$4.78B
$2.9M 0.01%
26,033
PDD icon
905
Pinduoduo
PDD
$122B
$2.88M 0.01%
31,750
+50
+0.2% +$4.86K
WPC icon
906
W.P. Carey
WPC
$16.8B
$2.87M 0.01%
40,125
-21,640
-35% -$1.65M
MSTR icon
907
Strategy Inc
MSTR
$35.1B
$2.87M 0.01%
49,620
-73,870
-60% -$4.74M
FBP icon
908
First Bancorp
FBP
$4.47B
$2.87M 0.01%
218,000
OM icon
909
Outset Medical
OM
$87.5M
$2.86M 0.01%
3,859
+407
+12% +$277K
LOPE icon
910
Grand Canyon Education
LOPE
$3.99B
$2.85M 0.01%
32,400
ARGX icon
911
argenx
ARGX
$54.6B
$2.85M 0.01%
9,423
+843
+10% +$267K
CRL icon
912
Charles River Laboratories
CRL
$11.6B
$2.84M 0.01%
6,877
+3,487
+103% +$1.45M
CAKE icon
913
Cheesecake Factory
CAKE
$4.42B
$2.83M 0.01%
60,317
SFNC icon
914
Simmons First National
SFNC
$3.39B
$2.83M 0.01%
95,740
SAH icon
915
Sonic Automotive
SAH
$3.31B
$2.83M 0.01%
53,851
ADPT icon
916
Adaptive Biotechnologies
ADPT
$3.6B
$2.82M 0.01%
83,064
+6,032
+8% +$218K
ACIW icon
917
ACI Worldwide
ACIW
$6.1B
$2.82M 0.01%
91,726
ASND icon
918
Ascendis Pharma A/S
ASND
$16.7B
$2.82M 0.01%
17,685
-11,000
-38% -$1.51M
MZTI
919
The Marzetti Company
MZTI
$3.02B
$2.82M 0.01%
16,683
GATX icon
920
GATX Corp
GATX
$6.6B
$2.81M 0.01%
31,339
DAN icon
921
Dana Inc
DAN
$2.95B
$2.8M 0.01%
125,879
FANG icon
922
Diamondback Energy
FANG
$53.5B
$2.79M 0.01%
29,460
+3,890
+15% +$313K
HP icon
923
Helmerich & Payne
HP
$3.31B
$2.79M 0.01%
101,600
ROG icon
924
Rogers Corp
ROG
$2.13B
$2.78M 0.01%
14,902
HOMB icon
925
Home BancShares
HOMB
$6.31B
$2.76M 0.01%
117,326

Similar funds

Ensign Peak Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Ensign Peak Advisors held 1,904 positions worth $48B, down 3.2% from $49.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ensign Peak Advisors withdrew a net $1.46B in Q3 2021, closing 55 positions and reducing 502 holdings. Its most notable exit was Root, an estimated $29.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in State Street SPDR S&P Biotech ETF worth $37.7M.

  • Ensign Peak Advisors's largest Q3 2021 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $37.7M.
  • Ensign Peak Advisors added most to AbbVie in Q3 2021, an estimated $60.6M increase.
  • Ensign Peak Advisors's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $92.3M.
  • Ensign Peak Advisors fully exited Root in Q3 2021, selling an estimated $29.6M.
  • Ensign Peak Advisors's ten largest holdings make up 24% of its $48B portfolio in Q3 2021.
  • Ensign Peak Advisors opened 84 new positions and closed 55 in Q3 2021.
  • Ensign Peak Advisors's portfolio value fell 3.2% quarter-over-quarter to $48B.

Based on Ensign Peak Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.